Wuhan Hiteck Biological PharmaLtd Balance Sheet Health
Financial Health criteria checks 4/6
Wuhan Hiteck Biological PharmaLtd has a total shareholder equity of CN¥2.5B and total debt of CN¥52.5M, which brings its debt-to-equity ratio to 2.1%. Its total assets and total liabilities are CN¥3.0B and CN¥487.2M respectively.
Key information
2.1%
Debt to equity ratio
CN¥52.46m
Debt
Interest coverage ratio | n/a |
Cash | CN¥1.05b |
Equity | CN¥2.48b |
Total liabilities | CN¥487.24m |
Total assets | CN¥2.97b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 300683's short term assets (CN¥1.5B) exceed its short term liabilities (CN¥311.0M).
Long Term Liabilities: 300683's short term assets (CN¥1.5B) exceed its long term liabilities (CN¥176.2M).
Debt to Equity History and Analysis
Debt Level: 300683 has more cash than its total debt.
Reducing Debt: 300683's debt to equity ratio has increased from 0% to 2.1% over the past 5 years.
Debt Coverage: 300683's debt is well covered by operating cash flow (65.7%).
Interest Coverage: Insufficient data to determine if 300683's interest payments on its debt are well covered by EBIT.